{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:43:57Z","timestamp":1792183437148,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 17H03594"],"award-info":[{"award-number":["JP 17H03594"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 16H06277 CoBiA"],"award-info":[{"award-number":["JP 16H06277 CoBiA"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Both natural viral infections and therapeutic interventions using viral vectors pose significant risks of malignant transformation. Monitoring for clonal expansion of infected cells is important for detecting cancer. Here we developed a novel method of tracking clonality via the detection of transgene integration sites. RAISING (Rapid Amplification of Integration Sites without Interference by Genomic DNA contamination) is a sensitive, inexpensive alternative to established methods. Its compatibility with Sanger sequencing combined with our CLOVA (Clonality Value) software is critical for those without access to expensive high throughput sequencing. We analyzed samples from 688 individuals infected with the retrovirus HTLV-1, which causes adult T-cell leukemia\/lymphoma (ATL) to model our method. We defined a clonality value identifying ATL patients with 100% sensitivity and 94.8% specificity, and our longitudinal analysis also demonstrates the usefulness of ATL risk assessment. Future studies will confirm the broad applicability of our technology, especially in the emerging gene therapy sector.<\/jats:p>","DOI":"10.1038\/s42003-022-03467-w","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T06:07:35Z","timestamp":1654150055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["RAISING is a high-performance method for identifying random transgene integration sites"],"prefix":"10.1038","volume":"5","author":[{"given":"Yusaku","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-784X","authenticated-orcid":false,"given":"Takahiro","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naganori","family":"Nao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariella L. G.","family":"Coler-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-9732","authenticated-orcid":false,"given":"Tomohiro","family":"Okagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michikazu","family":"Tanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Kuramitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyoshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Yagishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekatsu","family":"Iha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Konnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-0345","authenticated-orcid":false,"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-1186","authenticated-orcid":false,"given":"Masumichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"3467_CR1","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","volume":"10","author":"PS Moore","year":"2010","unstructured":"Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878\u2013889 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"3467_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ng.3178","volume":"47","author":"Z Hu","year":"2015","unstructured":"Hu, Z. et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat. Genet. 47, 158\u2013163 (2015).","journal-title":"Nat. Genet."},{"key":"3467_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15264","volume":"8","author":"N Rosewick","year":"2017","unstructured":"Rosewick, N. et al. Cis-perturbation of cancer drivers by the HTLV-1\/BLV proviruses is an early determinant of leukemogenesis. Nat. Commun. 8, 15264 (2017).","journal-title":"Nat. Commun."},{"key":"3467_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3513","volume":"4","author":"KW Tang","year":"2013","unstructured":"Tang, K. W., Alaei-Mahabadi, B., Samuelsson, T., Lindh, M. & Larsson, E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat. Commun. 4, 2513 (2013).","journal-title":"Nat. Commun."},{"key":"3467_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa012616","volume":"346","author":"S Hacein-Bey-Abina","year":"2002","unstructured":"Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185\u20131193 (2002).","journal-title":"N. Engl. J. Med."},{"key":"3467_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMra032207","volume":"350","author":"MP McCormack","year":"2004","unstructured":"McCormack, M. P. & Rabbitts, T. H. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 350, 913\u2013922 (2004).","journal-title":"N. Engl. J. Med."},{"key":"3467_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.omtn.2019.02.027","volume":"16","author":"SH Khan","year":"2019","unstructured":"Khan, S. H. Genome-editing technologies: concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. Mol. Ther. Nucleic Acids 16, 326\u2013334 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3467_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"3467_CR9","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"XH Zhang","year":"2015","unstructured":"Zhang, X. H., Tee, L. Y., Wang, X. G., Huang, Q. S. & Yang, S. H. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol. Ther. Nucleic Acids 4, e264 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3467_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/gm568","volume":"6","author":"S Firouzi","year":"2014","unstructured":"Firouzi, S. et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 6, 46 (2014).","journal-title":"Genome Med."},{"key":"3467_CR11","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet, N. A. et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117, 3113\u20133122 (2011).","journal-title":"Blood"},{"key":"3467_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","volume":"29","author":"H Katsuya","year":"2019","unstructured":"Katsuya, H. et al. The nature of the HTLV-1 provirus in naturally infected individuals analyzed by the viral DNA-Capture-Seq approach. Cell Rep. 29, 724\u2013735 e724 (2019).","journal-title":"Cell Rep."},{"key":"3467_CR13","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.1073\/pnas.1920346117","volume":"117","author":"M Nagasaka","year":"2020","unstructured":"Nagasaka, M. et al. Mortality and risk of progression to adult T cell leukemia\/lymphoma in HTLV-1-associated myelopathy\/tropical spastic paraparesis. Proc. Natl Acad. Sci. USA 117, 11685\u201311691 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3467_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth1103","volume":"4","author":"M Schmidt","year":"2007","unstructured":"Schmidt, M. et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 4, 1051\u20131057 (2007).","journal-title":"Nat. Methods"},{"key":"3467_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/nm.2057","volume":"15","author":"R Gabriel","year":"2009","unstructured":"Gabriel, R. et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nat. Med. 15, 1431\u20131436 (2009).","journal-title":"Nat. Med."},{"key":"3467_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/nprot.2010.87","volume":"5","author":"A Paruzynski","year":"2010","unstructured":"Paruzynski, A. et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat. Protoc. 5, 1379\u20131395 (2010).","journal-title":"Nat. Protoc."},{"key":"3467_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.07.008","volume":"34","author":"M Hamada","year":"2018","unstructured":"Hamada, M. et al. Integration mapping of piggyBac-mediated CD19 chimeric antigen receptor T cells analyzed by novel tagmentation-assisted PCR. EBioMedicine 34, 18\u201326 (2018).","journal-title":"EBioMedicine"},{"key":"3467_CR18","first-page":"15","volume":"9","author":"M Helmy","year":"2016","unstructured":"Helmy, M., Awad, M. & Mosa, K. A. Limited resources of genome sequencing in developing countries: challenges and solutions. Appl. Transl. Genom. 9, 15\u201319 (2016).","journal-title":"Appl. Transl. Genom."},{"key":"3467_CR19","doi-asserted-by":"crossref","unstructured":"Saito, M. et al. A high-throughput detection method for the clonality of human T-cell leukemia virus type-1-infected cells in vivo. Int. J. Hematol. 112, 300\u2013306 (2020).","DOI":"10.1007\/s12185-020-02935-5"},{"key":"3467_CR20","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz, B. J. et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA 77, 7415\u20137419 (1980).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3467_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain, A. & Cassar, O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3, 388 (2012).","journal-title":"Front. Microbiol."},{"key":"3467_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain, A. et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407\u2013410 (1985).","journal-title":"Lancet"},{"key":"3467_CR23","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma, Y. et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl Acad. Sci. USA 78, 6476\u20136480 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3467_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame, M. et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031\u20131032 (1986).","journal-title":"Lancet"},{"key":"3467_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga, M. et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116, 1211\u20131219 (2010).","journal-title":"Blood"},{"key":"3467_CR26","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1182\/blood.2019002665","volume":"135","author":"AG Rowan","year":"2020","unstructured":"Rowan, A. G. et al. Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis. Blood 135, 2023\u20132032 (2020).","journal-title":"Blood"},{"key":"3467_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2141.2004.05289.x","volume":"128","author":"H Hasegawa","year":"2005","unstructured":"Hasegawa, H. et al. Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand. Br. J. Haematol. 128, 253\u2013265 (2005).","journal-title":"Br. J. Haematol."},{"key":"3467_CR28","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1084\/jem.162.6.2169","volume":"162","author":"M Maeda","year":"1985","unstructured":"Maeda, M. et al. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J. Exp. Med. 162, 2169\u20132174 (1985).","journal-title":"J. Exp. Med."},{"key":"3467_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/aid.2012.0132","volume":"29","author":"MA Demontis","year":"2013","unstructured":"Demontis, M. A., Hilburn, S. & Taylor, G. P. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res. Hum. Retroviruses 29, 359\u2013364 (2013).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"3467_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai, M. et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J. Neurovirol. 4, 586\u2013593 (1998).","journal-title":"J. Neurovirol."},{"key":"3467_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1086\/342953","volume":"186","author":"AM Vine","year":"2002","unstructured":"Vine, A. M. et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J. Infect. Dis. 186, 932\u2013939 (2002).","journal-title":"J. Infect. Dis."},{"key":"3467_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","volume":"129","author":"TAdult Watanabe","year":"2017","unstructured":"Watanabe, T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood 129, 1071\u20131081 (2017).","journal-title":"Blood"},{"key":"3467_CR33","doi-asserted-by":"crossref","unstructured":"Marcais, A. et al. Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia\/lymphoma and defines an unfavorable indolent subtype. Leukemia. 35, 764\u2013776 (2020).","DOI":"10.1038\/s41375-020-0900-3"},{"key":"3467_CR34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka, K. et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat. Genet. 47, 1304\u20131315 (2015).","journal-title":"Nat. Genet."},{"key":"3467_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama, M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br. J. Haematol. 79, 428\u2013437 (1991).","journal-title":"Br. J. Haematol."},{"key":"3467_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/clim.1999.4700","volume":"91","author":"H Akari","year":"1999","unstructured":"Akari, H. et al. Effects of SIVmac infection on peripheral blood CD4+CD8+ T lymphocytes in cynomolgus macaques. Clin. Immunol. 91, 321\u2013329 (1999).","journal-title":"Clin. Immunol."},{"key":"3467_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/JCM.02254-14","volume":"53","author":"M Kuramitsu","year":"2015","unstructured":"Kuramitsu, M. et al. Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1. J. Clin. Microbiol. 53, 587\u2013596 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"3467_CR38","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1128\/jvi.69.6.3712-3720.1995","volume":"69","author":"P Lusso","year":"1995","unstructured":"Lusso, P. et al. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69, 3712\u20133720 (1995).","journal-title":"J. Virol."},{"key":"3467_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59\u201374 (1977).","journal-title":"J. Gen. Virol."},{"key":"3467_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4713-y","volume":"19","author":"Y Miyasaka","year":"2018","unstructured":"Miyasaka, Y. et al. CLICK: one-step generation of conditional knockout mice. BMC Genom. 19, 318 (2018).","journal-title":"BMC Genom."},{"key":"3467_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano, Y. et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood 99, 88\u201394 (2002).","journal-title":"Blood"},{"key":"3467_CR42","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/JCM.01628-15","volume":"53","author":"M Kuramitsu","year":"2015","unstructured":"Kuramitsu, M. et al. Standardization of quantitative PCR for human T-cell leukemia virus Type 1 in Japan: a Collaborative Study. J. Clin. Microbiol. 53, 3485\u20133491 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"3467_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"3467_CR44","unstructured":"Chang, W. et al. shiny: Web application framework for R. https:\/\/CRAN.R-project.org\/package=shiny (2014)."},{"key":"3467_CR45","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/dvdy.24183","volume":"243","author":"JT Hill","year":"2014","unstructured":"Hill, J. T. et al. Poly peak parser: method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products. Dev. Dyn. 243, 1632\u20131636 (2014).","journal-title":"Dev. Dyn."},{"key":"3467_CR46","unstructured":"Stefan, M. B. et al. magrittr: a forward-pipe operator for R. https:\/\/cran.r-project.org\/web\/packages\/magrittr\/index.html (2014)."},{"key":"3467_CR47","unstructured":"Hadley, W. et al. dplyr: a grammar of data manipulation. https:\/\/cran.r-project.org\/web\/packages\/dplyr\/index.html (2020)."},{"key":"3467_CR48","unstructured":"Hadley, W. et al. tidyr: Tidy Messy data. https:\/\/cran.r-project.org\/web\/packages\/tidyr\/index.html (2020)."},{"key":"3467_CR49","unstructured":"Carson, S. et al. plotly: Create Interactive Web Graphics via \u2018plotly.js\u2019 https:\/\/cran.r-project.org\/web\/packages\/plotly\/index.html (2020)."},{"key":"3467_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2996-x","volume":"20","author":"GM Boratyn","year":"2019","unstructured":"Boratyn, G. M. et al. Magic-BLAST, an accurate RNA-seq aligner for long and short reads. BMC Bioinforma. 20, 405 (2019).","journal-title":"BMC Bioinforma."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03467-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:37:10Z","timestamp":1669347430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03467-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-526444\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"14 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.W., T.M., H.M., and M.S. are inventors on the pending patent application (PCT\/JP2020\/03907) for RAISING technology. This study was partially funded by FASMAC Co., Ltd. The funder provided support in the form of salaries for authors (Y.W. and T.M.) and partial research materials, but did not have any additional role such as the study design, data collection and analysis, decision to publish and preparation of the manuscript. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"535"}}